Adage Capital Partners Gp, L.L.C. Abeona Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,902,360 shares of ABEO stock, worth $22.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,902,360
Previous 3,249,994
20.07%
Holding current value
$22.6 Million
Previous $20.5 Million
5.45%
% of portfolio
0.04%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ABEO
# of Institutions
69Shares Held
28.7MCall Options Held
631KPut Options Held
2.9K-
Suvretta Capital Management, LLC New York, NY3.69MShares$21.3 Million0.85% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.53MShares$20.4 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.12MShares$12.2 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA2.08MShares$12 Million7.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$11.4 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $34.4M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...